Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: Role for nuclear factor-κB

Critical Care

Volumn 6, Issue 6, 2002, Pages 481-490

  Haddad, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Injury; Lung; NF B; Oxygen; Redox; Transcription factors

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; CATALASE; CHELATING AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYPOCHLOROUS ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; IRON; LISOFYLLINE; MUCOLYTIC AGENT; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLIPID; POLYMER; SUPEROXIDE DISMUTASE; THIOL; THIOL DERIVATIVE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TYLOXAPOL; UNINDEXED DRUG;

AIR POLLUTANT; AIRBORNE PARTICLE; AIRWAY CONDUCTANCE; ANTIINFLAMMATORY ACTIVITY; CELL DEATH; CELL DEGENERATION; CELL FUNCTION; CHRONIC BRONCHITIS; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; GAS EXCHANGE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INFLAMMATION; INGESTION; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION; LUNG INJURY; METABOLITE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIOXIDANTS; GENE EXPRESSION REGULATION; HUMANS; LUNG DISEASES; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION;

EID: 0036893153     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1839     Document Type: Review

References (70)

1. D'Angio CT, Finkelstein JN: Oxygen regulation of gene expression: a study in opposites. Mol Genet Metab 2000, 71:371-380.
2. Alder V, Yin Z, Tew KD, Ronai Z: Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
3. Crapo JD, Harmsen AG, Sherman MP, Musson RA: Pulmonary immunobiology and inflammation in pulmonary diseases. Am J Respir Crit Care Med 2000, 162:1983-1986.
4. Haddad JJ, Olver RE, Land SC: Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J Biol Chem 2000, 275:21130-21139.
5. Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46:705-716.
6. Baldwin AS: The transcription factor NF-κB and human disease. J Clin Invest 2001, 107:3-6.
7. Housset B: Free radicals and respiratory pathology. C R Seances Soc Biol Fil 1994, 188:321-333.
8. Morris PE, Bernard GR: Significance of glutathione in lung disease and implications for therapy. Am J Med Sci 1994, 307: 119-127.
9. Das KC, Lewis-Molock Y, White CW: Thiol modulation of TNF-α and IL-1 induced MnSOD gene expression and activation of NF-κB. Mol Cell Biochem 1995, 148:45-57.
10. Schwartz MD, Moore EE, Moore FA, Shenkar R, Moine P, Haenel JB, Abraham E: Nuclear factor-κB is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 1996, 24:1285-1292.
11. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW: In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996, 157:1630-1637.
12. Ghio AJ, Marshall BC, Diaz JL, Hasegawa T, Samuelson W, Povia D, Kennedy TP, Piantodosi CA: Tyloxapol inhibits NF-κB and cytokine release, scavenges HOCI and reduces viscosity of cystic fibrosis sputum. Am J Respir Crit Care Med 1996, 154: 783-788.
13. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, Abraham E: Hyperoxia activates NF-κB and increases TNF-α and IFN-γ gene expression in mouse pulmonary lymphocytes. J Immunol 1996, 157:3902-3908.
14. Le Tulzo Y, Shenkar R, Kaneko D, Moine P, Fantuzzi G, Dinarello CA, Abraham E: Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-κB regulation and cytokine expression. J Clin Invest 1997, 99:1516-1524.
15. Moine P, Shenkar R, Kaneko D, Le Tulzo Y, Abraham E: Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs. Am J Physiol 1997, 273:L185-L192.
16. Hierholzer C, Harbrecht B, Menezes JM, Kane J, MacMicking J, Nathan CF, Peitzman AB, Billiar TR, Tweardy DJ: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med 1998, 187:917-928.
17. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson RW, Rotstein OD: Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 1997, 17:608-616.
18. Wong HR, Wispe JR: The stress response and the lung. Am J Physiol 1997, 273:L1-L9.
19. Wong HR, Ryan M, Wispe JR: Stress response decreases NF-κB nuclear translocation and increases IκB-α expression in A549 cells. J Clin Invest 1997, 99:2423-2428.
20. Lentsch AB, Shanley TP, Sarma V, Ward PA: In vivo suppression of NF-κB and preservation of IκB-α by interleukin-10 and interleukin-13. J Clin Invest 1997, 100:2443-2448.
21. Lentsch AB, Czermak BJ, Bless NM, Ward PA: NF-κB activation during IgG immune complex-induced lung injury: requirements for TNF-α and IL-1β but not complement. Am J Pathol 1998, 152:1327-1336.
22. Lentsch AB, Czermak BJ, Jordan JA, Ward PA: Regulation of acute lung inflammatory injury by endogenous IL-13. J Immunol 1999, 162:1071-1076.
23. Ayad O, Stark JM, Fiedler MM, Menendez IY, Ryan MA, Wong HR: The heat shock response inhibits RANTES gene expression in cultured human lung epithelium. J Immunol 1998, 161:2594-2599.
24. Lentsch AB, Crouch LD, Jordan JA, Czermak BJ, Yun EC, Guo R, Sarma V, Diehl KM, Ward PA: Regulatory effects of interleukin-11 during acute lung inflammatory injury. J Leukoc Biol 1999, 66:151-157.
25. Pugin J, Dunn I, Jolliet P, Tassaux D, Magnenat JL, Nicod LP, Chevrolet JC: Activation of human macrophages by mechanical ventilation in vitro. Am J Physiol 1998, 275:L1040-L1050.
26. p38 inhibitor with anti-inflammatory actions (Vertex pharmaceuticals). Curr Opin Investig Drugs 2001, 2:1070-1076.
27. Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, KowaLczyk D, Lauterbach R: Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated pro-inflammatory cytokine (interleukin-6 and tumor necrosis factor-α) biosynthesis in alveolar epithelial cells. J Pharmacol Exp Ther 2002, 300:559-566.
28. Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, KowaLczyk D, Lauterbach R: Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-κB/nuclear factor-κB-sensitive pathway in alveolar epithelial cells. J Pharmacol Exp Ther 2002, 300: 567-576.
29. Degerman E, Belfrage P, Manganiello VC: Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 1997, 272:6823-6826.
30. Demoliou-Mason CD: Cyclic nucleotide phosphodiesterase inhibitors. Expt Opin Ther Patents 1995, 5:417-430.
31. Essayan DM: Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol 1999, 57:965-973.
32. Houslay MD, Milligan G: Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci 1997, 22: 217-224.
33. Lauterbach R, Szymura-Oleksiak J: Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia. Eur J Pediatr 1999, 158:607-610.
34. Lauterbach R, Pawlik D, KowaLczyk W, Helwich E, Zembala M: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 1999, 27: 807-814.
35. Perry MJ, Higgs GA: Chemotherapeutic potential of phosphodiesterase inhibitors. Curr Opin Chem Biol 1998, 2:472-481.
36. Rogers DF, Laurent GJ: New ideas on the pathophysiology and treatment of lung disease. Thorax 1998, 53:200-203.
37. Pittet JF, Wiener-Kronish JP, Serikov V, Matthay MA: Resistance of the alveolar epithelium to injury from septic shock in sheep. Am J Respir Crit Care Med 1995, 151:1093-1100.
38. George CL, Fantuzzi G, Bursten S, Leer L, Abraham E: Effects of lisofylline on hyperoxia-induced lung injury. Am J Physiol 1999, 276:L776-L785.
39. Shenkar R, Abraham E: Hemorrhage induces rapid in vivo activation of CREB and NF-κB in murine intraparenchymal lung mononuclear cells. Am J Respir Cell Mol Biol 1997, 16:145-152.
40. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, Rotstein OD: Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 1998, 161:440-447.
41. Leeper-Woodford SK, Detmer K: Acute hypoxia increases alveolar macrophage tumor necrosis factor activity and alters NF-κB expression. Am J Physiol 1999, 276:L909-L916.
42. Blackwell TS, Debelak JP, Venkatakrishnan A, Schot DJ, Harley DH, Pinson CW, Williams P, Washington K, Christman JW, Chapman WC: Acute lung injury after hepatic cryo-ablation: correlation with NF-κB activation and cytokine production. Surgery 1999,126:518-526.
43. Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ: Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 1999, 117:953-961.
44. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, McNamara N: Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med 1999, 160:S44-S48.
45. Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 inhibits pulmonary NF-κB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol 1999, 277: L919-L923.
46. Armstead VE, Opentanova IL, Minchenko AG, Lefer AM: Tissue factor expression in vital organs during murine traumatic shock: role of transcription factors AP-1 and NF-κB. Anesthesiology 1999, 91:1844-1852.
47. Chapman WC, Debelak JP, Wright Pinson C, Washington MK, Atkinson JB, Venkatakrishnan A, Blackwell TS, Christman JW: Hepatic cryo-ablation, but not radio-frequency ablation, results in lung inflammation. Ann Surg 2000, 231:752-761.
48. Chapman WC, Debelak JP, Blackwell TS, Gainer KA, Christman JW, Pinson CW, Brigham KL, Parker RE: Hepatic cryo-ablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model. Arch Surg 2000, 135: 667-672.
49. Washington K, Debelak JP, Gobbell C, Sztipanovits DR, Shyr Y, Olson S, Chapman WC: Hepatic cryo-ablation-induced acute lung injury: histopathologic findings. J Surg Res 2001, 95:1-7.
50. Ross SD, Kron IL, Gangemi JJ, Shockey KS, Stoler M, Kern JA, Tribble CG, Laubach VE: Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol 2000, 279:L528-L536.
51. -/- mice. Infect Immun 2001, 69:5138-5150.
52. Lentsch AB, Ward PA: Regulation of experimental lung inflammation. Respir Physiol 2001, 128:17-22.
53. Fan J, Ye RD, Malik AB: Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001, 281: L1037-L1050.
54. Kupfner JG, Arcaroli JJ, Yum HK, Nadler SG, Yang KY, Abraham E: Role of NF-κB in endotoxemia-induced alterations of lung neutrophil apoptosis. J Immunol 2001, 167:7044-7051.
55. Park GY, Le S, Park KH, Le CT, Kim YW, Han SK, Shim YS, Yoo CG: Anti-inflammatory effect of adenovirus-mediated IκB-α overexpression in respiratory epithelial cells. Eur Respir J 2001, 18:801-809.
56. Semenza GL: Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 2000, 1:159-162.
57. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, Thiemermann C: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002, 135:496-510.
58. Sunil VR, Connor AJ, Guo Y, Laskin JD, Laskin DL: Activation of type II alveolar epithelial cells during acute endotoxemia. Am J Physiol Lung Cell Mol Physiol 2002, 282:L872-L880.
59. 2/ROS)-dependent release of IL-1β, IL-6 and TNF-α: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium. Cytokine 2001, 13: 138-147.
60. Haddad JJ, Choudhary KK, Land SC: The ex vivo differential expression of apoptosis signaling cofactors in the developing perinatal lung: essential role of oxygenation during the transition from placental to pulmonary-based respiration. Biochem Biophys Res Commun 2001, 281:311-316.
61. Haddad JJ, Safieh-Garabedian B, Saadé NE, Land SC: Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium. J Pharmacol Exp Ther 2001, 296:996-1005.
62. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis. Am J Physiol Lung Cell Mol Physiol 2000, 278: L492-L503.
63. Haddad JJ, Land SC: The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting. Biochem Biophys Res Commun 2000, 271:257-267.
64. Chabot F, Mitchell JA, Gutteridge JMC, Evans TW: Reactive oxygen species in acute lung injury. Eur Respir J 1998, 11: 745-757.
65. van der Vliet A, Cross CE: Oxidants, nitrosants, and the lung. Am J Med 2000, 109:398-421.
66. Schreck R, Albermann K, Baeuerle PA: Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun 1992, 17:221-237.
67. Li N, Karin M: Is NF-κB the sensor of oxidative stress? FASEB J 1999,13:1137-1143.
68. 193-195 receptor antagonism in the alveolar epithelium. Biochem J 2001, 355: 29-38.
69. Bruick RK, McKnight SL: Transcription enhanced: oxygen sensing gets a second wind. Science 2002, 295:807-808.
70. Haddad JJ: Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 2002, 14:799-810.